`571-272-7822
`
`
`Paper No. 3
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`____________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`____________
`
`COMPLEX INNOVATIONS, LLC,
`Petitioner,
`
`v.
`
`AMGEN INCORPORATED,
`Patent Owner.
`____________
`
`Case IPR2016-00085
`Patent 7,829,595
`____________
`
`Mailed: November 2, 2015
`
`Before KAREN HILASKI, Trial Paralegal, Trial Paralegal
`
`NOTICE OF FILING DATE ACCORDED TO PETITION
`AND
`TIME FOR FILING PATENT OWNER PRELIMINARY RESPONSE
`
`The petition for inter partes review in the above proceeding has been
`accorded the filing date of October 26, 2015.
`A review of the petition identified the following defect(s):
`Each exhibit must have a label with the petitioner’s name
`and exhibit number affixed to the lower right corner of the
`first page without obscuring information on the first page
`(or affixed to a duplicate first page if obscuring is
`unavoidable). See 37 C.F.R. § 42.63(d).
`
`
`
`Case IPR2016-00085
`Patent 7,829,595
`
`
`Petitioner must correct the defect(s) within FIVE BUSINESS DAYS
`from this notice. Failure to correct the defect(s) may result in an order to
`show cause as to why the Board should institute the trial. No substantive
`changes (e.g., new grounds) may be made to the petition.
`Patent Owner may file a preliminary response to the petition no later
`than three months from the date of this notice. The preliminary response is
`limited to setting forth the reasons why the requested review should not be
`instituted. Patent Owner may also file an election to waive the preliminary
`response to expedite the proceeding. For more information, please consult
`the Office Patent Trial Practice Guide, 77 Fed. Reg. 48756 (Aug. 14, 2012),
`which is available on the Board Web site at http://www.uspto.gov/PTAB.
`Patent Owner is advised of the requirement to submit mandatory
`notice information under 37 C.F.R. § 42.8(a)(2) within 21 days of service of
`the petition.
`The parties are encouraged to use the heading on the first page of this
`Notice for all future filings in the proceeding.
`The parties are advised that under 37 C.F.R. § 42.10(c), recognition of
`counsel pro hac vice requires a showing of good cause. The parties are
`authorized to file motions for pro hac vice admission under 37 C.F.R.
`§ 42.10(c). Such motions shall be filed in accordance with the “Order --
`Authorizing Motion for Pro Hac Vice Admission” in Case IPR2013-00639,
`Paper 7, a copy of which is available on the Board Web site under
`“Representative Orders, Decisions, and Notices.”
`
`
`
`2
`
`
`
`Case IPR2016-00085
`Patent 7,829,595
`
`
`The parties are reminded that unless otherwise permitted by 37 C.F.R.
`§ 42.6(b)(2), all filings in this proceeding must be made electronically in the
`Patent Review Processing System (PRPS), accessible from the Board Web
`site at http://www.uspto.gov/PTAB.
`If there are any questions pertaining to this notice, please contact
`Karen Hilaski at 571-272-2873 or the Patent Trial and Appeal Board at
`571-272-7822.
`
`
`PETITIONER:
`
`Vivek Ganti (vg@hkw-law.com)
`Sharad Bijanki (sb@hkw-law.com)
`HILL, KERTSCHER, & WHARTON, LLP
`3350 Riverwood Pkwy, Suite 800
`Atlanta, GA 30339
`
`
`PATENT OWNER:
`
`AMGEN INC.
`Law - Patent Operations, M/S 28-2-C
`One Amgen Center Drive
`Thousand Oaks, CA 91320-1799
`
`
`
`3
`
`